Join to View Full Profile
825 Eastlake Ave ESeattle, WA 98109
Phone+1 206-677-5925
Are you Dr. Milano?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Filippo Milano, MD is a hematologist in Seattle, Washington. He is currently licensed to practice medicine in Washington and Idaho.
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 2013 - 2016
Sapienza University of RomeClass of 2001
Certifications & Licensure
ID State Medical License 2022 - 2025
WA State Medical License 2009 - 2025- WA State Medical License 2015 - 2025
Publications & Presentations
PubMed
- Donor Type Does Not Impact Late Graft Failure Following Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based Gra...Cindy Lynn Hickey, Mei-Jie Zhang, Mariam Allbee-Johnson, Rizwan Romee, Navneet S Majhail
Transplantation and Cellular Therapy. 2025-03-01 - Long-Term Outcomes and Quality of Life with Treosulfan-Based Conditioning in Hematological Malignancies.Rohtesh S Mehta, Stephanie J Lee, Ted A Gooley, Laurel Thur, Ann Dahlberg
Blood Advances. 2025-02-19 - 1 citationsMeasurable residual disease as predictor of post-day +100 relapses after allografting in adult AML.Naveed Ali, Megan Othus, Eduardo Rodríguez-Arbolí, Corentin Orvain, Filippo Milano
Blood Advances. 2025-02-11
Press Mentions
Grafapex Approved as Part of Conditioning Regimen for HSCT in AML, MDS PatientsJanuary 27th, 2025- FDA Approves Treosulfan as Part of AML/MDS Conditioning RegimenJanuary 22nd, 2025
- Testing Cord Blood Transplants as a Cure for Leukemia — and HIVMarch 10th, 2022
- Join now to see all
